Latest period
$3.26B
YoY change
+81.2%
5Y CAGR
-0.4%
Peak year (2020)
$10.32B
Latest annual
$10.11B
Cash on Hand history chart for Thermo Fisher Scientific (TMO) from 1985 to 2025
Latest: $10.11B
Cash on Hand growth chart for Thermo Fisher Scientific (TMO) from 1985 to 2025
Latest: +81.2%
Cash on Hand history table for Thermo Fisher Scientific (TMO) from 1985 to 2025
| 2025 | $10.11B | +81.2% | +$4.53B | ||
| 2024 | $5.58B | -31.0% | −$2.50B | ||
| 2023 | $8.08B | -5.2% | −$441.00M | ||
| 2022 | $8.52B | +90.4% | +$4.05B | ||
| 2021 | $4.48B | -56.6% | −$5.85B | ||
| 2020 | $10.32B | +330.4% | +$7.93B | ||
| 2019 | $2.40B | +14.1% | +$296.00M | ||
| 2018 | $2.10B | +57.5% | +$768.00M | ||
| 2017 | $1.33B | +69.8% | +$549.00M | ||
| 2016 | $786.00M | +73.9% | +$333.90M | ||
| 2015 | $452.10M | -66.3% | −$891.40M | ||
| 2014 | $1.34B | -77.0% | −$4.49B | ||
| 2013 | $5.83B | +619.9% | +$5.02B | ||
| 2012 | $809.90M | -20.6% | −$210.70M | ||
| 2011 | $1.02B | +10.2% | +$94.60M | ||
| 2010 | $926.00M | -41.1% | −$645.20M | ||
| 2009 | $1.57B | +22.0% | +$283.20M | ||
| 2008 | $1.29B | +101.5% | +$648.80M | ||
| 2007 | $639.20M | -7.5% | −$52.00M | ||
| 2006 | $691.20M | +134.3% | +$396.21M | ||
| 2005 | $294.99M | -42.4% | −$217.27M | ||
| 2004 | $512.25M | +22.5% | +$94.02M | ||
| 2003 | $418.24M | -52.2% | −$457.23M | ||
| 2002 | $875.47M | -16.0% | −$166.53M | ||
| 2001 | $1.04B | +1.5% | +$15.00M | ||
| 2000 | $1.03B | +22.6% | +$189.00M | ||
| 1999 | $838.00M | -45.9% | −$710.00M | ||
| 1998 | $1.55B | +1.6% | +$25.00M | ||
| 1997 | $1.52B | -17.5% | −$323.00M | ||
| 1996 | $1.85B | +74.8% | +$790.00M | ||
| 1995 | $1.06B | +175.9% | +$673.20M | ||
| 1994 | $382.80M | +17.5% | +$57.10M | ||
| 1993 | $325.70M | +70.9% | +$135.10M | ||
| 1992 | $190.60M | +45.5% | +$59.60M | ||
| 1991 | $131.00M | +11.1% | +$13.10M | ||
| 1990 | $117.90M | +25.6% | +$24.00M | ||
| 1989 | $93.90M | -31.2% | −$42.50M | ||
| 1988 | $136.40M | -5.3% | −$7.70M | ||
| 1987 | $144.10M | +125.9% | +$80.30M | ||
| 1986 | $63.80M | +112.7% | +$33.80M | ||
| 1985 | $30.00M | — | — |
- 2025$10.11B+81.2%
- 2024$5.58B-31.0%
- 2023$8.08B-5.2%
- 2022$8.52B+90.4%
- 2021$4.48B-56.6%
- 2020$10.32B+330.4%
- 2019$2.40B+14.1%
- 2018$2.10B+57.5%
- 2017$1.33B+69.8%
- 2016$786.00M+73.9%
- 2015$452.10M-66.3%
- 2014$1.34B-77.0%
- 2013$5.83B+619.9%
- 2012$809.90M-20.6%
- 2011$1.02B+10.2%
- 2010$926.00M-41.1%
- 2009$1.57B+22.0%
- 2008$1.29B+101.5%
- 2007$639.20M-7.5%
- 2006$691.20M+134.3%
- 2005$294.99M-42.4%
- 2004$512.25M+22.5%
- 2003$418.24M-52.2%
- 2002$875.47M-16.0%
- 2001$1.04B+1.5%
- 2000$1.03B+22.6%
- 1999$838.00M-45.9%
- 1998$1.55B+1.6%
- 1997$1.52B-17.5%
- 1996$1.85B+74.8%
- 1995$1.06B+175.9%
- 1994$382.80M+17.5%
- 1993$325.70M+70.9%
- 1992$190.60M+45.5%
- 1991$131.00M+11.1%
- 1990$117.90M+25.6%
- 1989$93.90M-31.2%
- 1988$136.40M-5.3%
- 1987$144.10M+125.9%
- 1986$63.80M+112.7%
- 1985$30.00M—
Cash on Hand values are taken from Thermo Fisher Scientific's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at Thermo Fisher Scientific (TMO)
According to Thermo Fisher Scientific's latest reported financial statements, the company's latest reported cash and short-term investments is $3.26B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Thermo Fisher Scientific (TMO) cash and short-term investments is $10.11B – surged 81.2% year-over-year.
Thermo Fisher Scientific cash and short-term investments compound annual growth for the 2020–2025 (5 years) window is -0.4%, with a net decline across the window.
Thermo Fisher Scientific cash and short-term investments peaked at $10.32B in 2020; the latest annual figure is $10.11B in 2025 (2.1% below peak).
$10.32B stands as the all-time-high annual cash and short-term investments, posted in 2020, against a low of $30.00M during 1985.
Thermo Fisher Scientific Cash on Hand by Year
Thermo Fisher Scientific Cash on Hand 2025: $10.11B
2025's cash and short-term investments for Thermo Fisher Scientific came in at $10.11B, surged 81.2% from 2024.
Thermo Fisher Scientific Cash on Hand 2024: $5.58B
Thermo Fisher Scientific posted cash and short-term investments of $5.58B in 2024, plunged 31.0% below 2023.
Thermo Fisher Scientific Cash on Hand 2023: $8.08B
In 2023, Thermo Fisher Scientific reported cash and short-term investments of $8.08B, declined 5.2% below 2022.
Thermo Fisher Scientific Cash on Hand 2022: $8.52B
Thermo Fisher Scientific cash and short-term investments in 2022 was $8.52B, surged 90.4% from 2021.
Thermo Fisher Scientific Cash on Hand 2021: $4.48B
Thermo Fisher Scientific cash and short-term investments in 2021 was $4.48B.
See more financial history for Thermo Fisher Scientific (TMO).
Sector peers by Cash on Hand
Healthcare peers of Thermo Fisher Scientific (TMO), ranked by their latest cash and short-term investments
| $28.12B | |
| $20.10B | |
| $14.56B | |
| $9.13B | |
| $7.27B | |
| $5.74B | |
| $5.26B | |
| $4.24B |
- $28.12B
- $20.10B
- $14.56B
- $9.13B
- $7.27B
- $5.74B
- $5.26B
- $4.24B
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation